Year: 2026
Type: article
Source: Cancer Science
DOI: 10.1111/cas.70506
Authors: Keita H. Nagaoka, Hiroki Yamashita, Chiaki Mashima, Guoqiang Zhang, Hitoshi Saito, Tatsunori Minamide, Takuya Nakatsuru, Ryo Kamata, Shunsuke A. Sakai, Gaku Yamamoto, Tomoko Y. Morita, Kazuki Nakai, Yumi Hakozaki, Kumi Kinoshita, Yui Takahashi, Izuma Nakayama, Akihito Kawazoe, Sai M. Pulukuri, Yuko Ishii, Hiroshi Haeno, Yukie Kashima, Kohei Shitara, Tomonori Yano, Takeshi Saito, Akihiro Ohashi
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,600
Awards: Study on the Elucidation of the Cancer Chromosomal Instability (CIN) Paradox and the Development of Novel Therapeutic Strategies Targeting CIN Vulnerabilities, Combination treatment with CDC7 inhibitor and DNA damage agents enhances antiproliferative activity in multiple preclinical models, A novel germline mutation in the non-coding region of BRCA2 is associated with hereditary breast cancer
OpenAlex ID: W7204039845